People who have depended on off-brand versions of Wegovy and Ozempic will likely have to pay more now that a nationwide ...

Health-care professionals, eager to support their patients diagnosed with diabetes or obesity, are writing more prescriptions ...

After the FDA removed semaglutide injection products from a shortage list, compounders like Hims have 60-90 days to stop ...

Consumers who use telehealth or medical spas to get less expensive, compounded weight loss drugs will need to get their ...

The FDA has now resolved the shortages of Novo Nordisk’s and Eli Lilly’s blockbuster weight-loss drugs, which could spell the ...

Some workers are willing to trade vacation days or go back to the office in exchange for weight-loss drug coverage by their ...

However, this also allowed pharmacies to offer these drugs at lower costs. The list cost of Wegovy is $1,349, and one dose is generally taken every four weeks. “Non-FDA approved compounded drugs ...

The agency first declared a shortage of semaglutide, the main ingredient used to make Ozempic and Wegovy, in 2022.

The FDA has resolved the shortage of Wegovy and Ozempic, but companies like Hims and Hers may halt sales of compounded ...

North Carolina is facing a $500 million dollar problem. State officials say the state is running out of money to pay for the ...

People with a high body weight living in England can now access subsidised weight-loss drugs to treat their obesity.